Guardian Wealth Advisors, LLC Amgen Inc Transaction History

Guardian Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$225.79 - $275.2 $34,997 - $42,656	155 New	155 $37,000
Q3 2022 Nov 09, 2022	BUY	$224.46 - $253.15 $185,628 - $209,355	827 New	827 $187,000
Q2 2021 Jul 28, 2021	SELL	$233.58 - $259.14 $2.02 Million - $2.24 Million	-8,628 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$221.91 - $258.6 $1.91 Million - $2.23 Million	8,628 New	8,628 $2.15 Million

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $151B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Guardian Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Guardian Wealth Advisors, LLC with notifications on news.